Synthetic Biologics Inc (NYSE MKT LLC:SYN)

Data as of Jan 30
 -0.07 / -3.98%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Synthetic Biologics, Inc. is a biotechnology company focused on the development of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases. It is developing an oral biologic to protect the gastrointestinal microflora from the effects of IV antibiotics for the prevention of C. diff infection, an oral treatment to reduce the impact of methane producing organisms on conditions such as constipation-predominant irritable bowel syndrome (C-IBS), a series of monoclonal antibodies for the treatment of Pertussis and Acinetobacter infections, and a biologic targeted at the prevention and treatment of a root cause of a subset of IBS. The company was founded by Steven H. Kanzer in January 2001 and is headquartered in Rockville, MD.

Contact Information

Synthetic Biologics, Inc.
155 Gibbs Street
Rockville Maryland 20850
P:(734) 332-7800
Investor Relations:



Individual stakeholders23.47%
Mutual fund holders2.65%
Other institutional15.82%

Top Executives

Jeffrey Lucero RileyPresident, Chief Executive Officer & Director
Charles Evan BallantyneChief Financial Officer, Secretary & Treasurer
John James MonahanExecutive Vice President-Research & Development
Joseph SlimanSenior VP-Clinical & Regulatory Affairs
Lara M. GuzmanSenior Director-Project Operations

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.